Harel Insurance Investments & Financial Services’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Harel Insurance Investments & Financial Services’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,000	Closed	-$270K	–	504
2017 Q4	$270K	Sell	5,000 -4,000	-44%	-$219K	0.02%	187
2017 Q3	$514K	Sell	9,000 -1,550	-15%	-$90.8K	0.04%	91
2017 Q2	$635K	Buy	10,550 +4,376	+71%	+$249K	0.05%	92
2017 Q1	$347K	Buy	+6,174	New	+$304K	0.03%	118

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Harel Insurance Investments & Financial Services's BIVV Position: Q1 2018 in Review

Harel Insurance Investments & Financial Services sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 5,000 shares — an estimated $270K sold.

Harel Insurance Investments & Financial Services first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $635K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Harel Insurance Investments & Financial Services reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Harel Insurance Investments & Financial Services sold 5,000 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $270K.
Harel Insurance Investments & Financial Services first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Harel Insurance Investments & Financial Services's Bioverativ Inc. Common Stock position peaked at $635K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2018, filed 30 Apr 2018.